Target Name: CCDC81
NCBI ID: G60494
Review Report on CCDC81 Target / Biomarker Content of Review Report on CCDC81 Target / Biomarker
CCDC81
Other Name(s): Coiled-coil domain containing 81 | Coiled-coil domain-containing protein 81 (isoform 1) | CCD81_HUMAN | OTTHUMP00000235497 | CCDC81 variant 1 | Coiled-coil domain-containing protein 81 | FLJ16339 | OTTHUMP00000235496 | OTTHUMP00000235494 | FLJ23514 | coiled-coil domain containing 81 | Coiled-coil domain containing 81, transcript variant 1

CDC81: A Protein with Unique Features and Potential as A Drug Target

CCDC81, also known as Coiled-coil domain containing 81, is a protein that is found in various tissues throughout the body. It is a unique protein that is composed of a combination of multiple domains, including a coiled-coil domain. The coiled-coil domain is a type of protein structure that is characterized by the presence of a positively charged region that is made up of multiple amino acids that are wrapped together in a specific pattern.

CDC81 is a protein that is expressed in a wide range of tissues, including the brain, heart, liver, and muscle. It is also involved in several important cellular processes that are critical for the survival and function of these tissues. For example, CDC81 is involved in the regulation of cell division, which is essential for the growth and development of tissues. It is also involved in the regulation of cell death, which is important for maintaining tissue homeostasis and removing damaged or dysfunctional cells.

In addition to its role in cell regulation, CDC81 is also a potential drug target. Its unique protein structure and various functions make it an attractive target for drug development. The coiled-coil domain of CDC81 has been shown to be involved in several different processes in the body, including cell signaling and transport. This suggests that targeting this domain may be a promising way to develop new treatments for a variety of diseases.

One of the challenges in developing new treatments for diseases is identifying the specific targets of the disease and developing effective strategies to target those targets. This can be a difficult task, especially for diseases that are complex and difficult to study. However, the protein structure of CDC81 makes it an attractive target for drug development because of its unique features and the involvement of its various functions in cellular processes.

Targeting CDC81 may also be a promising approach to treating certain types of cancer. The coiled-coil domain of CDC81 has been shown to be involved in the regulation of cell signaling and transport, which is also involved in the development and progression of cancer. Therefore, targeting this domain may be a promising way to develop new treatments for certain types of cancer.

In conclusion, CDC81 is a protein that is expressed in a wide range of tissues and is involved in several important cellular processes. Its unique protein structure and various functions make it an attractive target for drug development. The coiled-coil domain of CDC81 has been shown to be involved in several different processes in the body, including cell signaling and transport. This suggests that targeting this domain may be a promising way to develop new treatments for a variety of diseases. Further research is needed to fully understand the functions of CDC81 and its potential as a drug target.

Protein Name: Coiled-coil Domain Containing 81

The "CCDC81 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC81 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCDC82 | CCDC83 | CCDC85A | CCDC85B | CCDC85C | CCDC86 | CCDC87 | CCDC88A | CCDC88B | CCDC88C | CCDC89 | CCDC9 | CCDC90B | CCDC91 | CCDC92 | CCDC92B | CCDC93 | CCDC96 | CCDC97 | CCDC9B | CCDST | CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1 | CCNT1